Skip to content
  • 6,808 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started

Presolicitation

Qiagen LLC DNA Isolation Kits

25-000010

National Institutes of Health, National Institutes of Health - CC. In-Vitro Diagnostic Substance Manufacturing.

Response deadline

October 31, 2024 at 6:30 AM EDT

Closed 731 days ago. Posted October 21, 2024. Scheduled to archive November 1, 2024.

Get the next one like this from National Institutes of Health by email, the day it is posted.Find my opportunities

This one closed in 2024

13 like it are open now in in-vitro diagnostic substance manufacturing

All 13 open in in-vitro diagnostic substance manufacturing

Description

As published on SAM.gov.

Title Qiagen LLC DNA Isolation Kits Product Service Code:

6550 NAICS Code:

325413 Place of Performance:

Bethesda, MD 20892 USA POTS: 25-000010 Description This is a notice of intent, NOT a request for a quotation. A solicitation document will NOT be issued, and quotations will NOT be requested. The National Institutes of Health (NIH) plans to issue a firm fixed-price purchase order to Qiagen LLC located in Germantown Maryland 20874-1415, on a sole source basis. The purpose of this acquisition is to purchase DNA Isolation Kits for the Human Leukocyte Antigen (HLA) Lab.

The HLA Laboratory offers both high and low-resolution HLA typing for patients at the NIH Clinical Center, often serving critically ill individuals. These testing kits have been rigorously tested by the HLA Lab to ensure the highest quality DNA samples for downstream testing. This contract will facilitate the shipment of testing kits on an as-needed basis throughout the year, preventing any risk of running out.

The quantity of kits procured is anticipated to meet the lab's needs for one year, based on current usage rates. The HLA Lab specifically requires Qiagen DNA isolation kits, as the lab's existing instrumentation is compatible only with these kits. Both the instrumentation and kits have undergone Quality Control testing by the HLA Lab, demonstrating their ability to produce the high-quality DNA necessary for Next Generation Sequencing testing mandated by CC clinicians.

Using an inferior product could significantly impact the turnaround time for HLA typing results, potentially delaying lifesaving transplants. The below items are required for this action: Quantity/Catalog #/Item 1/1002137/Freight 60/951054/EZ1 & 2 DNA Blood 350 Kit (48) 6/953034/ EZ1 & 2 DNA Tissue Kit (48) The proposed vendor, Qiagen LLC, is the exclusive manufacturer of the DNA isolation kits. There are no known vendors that can provide these specific reagents.

This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 – Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available.

Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government.

Comments to this announcement, referencing this posting number, may be submitted to the Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Shasheshe Goolsby, Lead Contract Specialist, shasheshe.goolsby@nih.gov by October 31, 2024, 6:30AM EST.

Please send your capability statements ONLY. This IS NOT a request for proposal.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. October 21, 2024

    Presolicitation

    Due October 31, 2024 at 6:30 AM EDT. SAM.gov, notice d94a99dd361a4adfb19207fd0ea73d5c

Points of contact